$RFIL

RF Industries Q2 2026 Earnings Call Transcript - RF Industries (NASDAQ: RFIL)

RF Industries (NASDAQ:RFIL) reported Q2 revenue of $20.7 million, up 9% year-over-year and sequentially, with gross margin of 35.1%. Adjusted EBITDA was $2.0 million (nearly double), and net income was $879,000 versus a loss last year. The company cited $26.3 million bookings, lifting backlog to $20 million, and expects Q3 sales to rise sequentially.

Original reporting
Published Jun 15, 2026, 10:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 15, 2026, 10:50 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
RF Industries Q2 2026 Earnings Call Transcript - RF Industries (NASDAQ: RFIL) — source image
Decision brief

The 30-second read

$RFILBullishMed
01

Why it matters

The most tradable elements are the newly disclosed Q2 financial metrics (revenue, gross margin, adjusted EBITDA, net income) and management’s sequential Q3 sales/margin-leverage expectations, plus $26.3M bookings supporting second-half momentum.

02

Market read

Fresh earnings datapoints and directional Q3 commentary can influence short- to medium-term positioning, especially for investors tracking profitability improvement and backlog conversion.

03

What to watch

Tariff uncertainty is acknowledged for July decisions, and working-capital/free-cash-flow conversion is discussed as a driver to watch rather than a guaranteed improvement.

Relevance 7/10Novelty 8/10Timing: Ahead of the next earnings print in September; Q3 sequential growth expectation discussed on the call.

Background

This is a transcript-style recap of RF Industries’ Q2 2026 earnings call, including management commentary on profitability, bookings/backlog, and index inclusion.

Company-level read

Ticker impact

$RFILBullishMedium confidence
Context

RF Industries reported Q2 revenue of $20.7M (+9% YoY), positive net income, and said Q3 sales should rise sequentially with margin expansion.

Expected impact

Moderate positive bias into Q3 as investors weigh improving profitability (gross margin/EBITDA) and $26.3M bookings/backlog momentum.

Evidence & confidence

The article includes multiple concrete Q2 results plus management’s sequential Q3 sales/margin-leverage commentary; however, it lacks specific guidance numbers and any explicit new contract award or revised forecast.

Market effects

Signals demand resilience in wireless carrier ecosystem/infrastructure and edge data center DAC systems, potentially supporting sentiment for industrial/custom cabling and integrated systems suppliers.

No specific regional read-through provided beyond US investor visibility via Russell 3000 inclusion.

Limited—tariff environment mentioned but no quantified cross-border exposure or global demand shift disclosed.

Counterpoint

Sequential Q3 growth is directional and customer-release timing/inventory shifts may reverse; bookings/backlog strength may not fully translate into near-term revenue without execution.

Key entities

  • RF Industries

    Reported Q2 results and discussed Q3 sequential growth, margin expansion, bookings/backlog, and Russell 3000 inclusion.

Related articles

$DFTXHighAI 9/10

Why is Definium Therapeutics stock surging today?

Definium Therapeutics (DFTX) stock surged 20.7% in pre-market trading after its Phase 3 trial of DT120 ODT for generalized anxiety disorder met its primary endpoint. The company has also received FDA Breakthrough Therapy designation for DT120 in major depressive disorder. Analysts had previously assigned Buy or Strong Buy ratings, with price targets above current levels. The stock is nearing its 52-week high of $49.70, up from a low of $8.77.

$CSHRMed

CoinShares PLC (CSHR): Financial results for H1 2026

CoinShares PLC (CSHR) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 CoinShares Announces First Half 2026 Results Positive net flows despite a sharp digital asset market decline; strong balance sheet with $453 million of net assets and no long-term debt JERSEY, Channel Islands — September 14, 2026 — CoinShares PLC (Nasdaq: CSHR) (“Coi

$LLYMed

Eli Lilly Fell Like a Rock Over the Last Month: This Big Bank Expects 45% Returns Over The Next Twelve

Eli Lilly (LLY) closed at $1,114.90, with a consensus 12-month price target of $1,318.66 and Citi's target at $1,600. LLY dropped 8.44% in a month due to pricing concerns and IPR&D charges, despite Q2 revenue growth of 48% and raised 2026 guidance. Citi sees 45% upside, citing strong market share and pipeline prospects. Analysts remain mostly bullish, with 6 Strong Buy, 18 Buy, and 4 Hold ratings.